March 16, 2021
PA-18-705 - SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
This notice informs applicants of an extension to PA-18-705, "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round to expire on September 6, 2021.
Due to the extension, the following dates have been added:
New, Renewal, Resubmission, and Revision Application Due Date: September 5, 2021.
The following section of PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)" has been modified, as indicated below.
Currently Reads:
Part 1. Overview
Key Dates
Application Due Date(s) |
Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard dates apply |
Advisory Council Review | Standard dates apply |
Earliest Start Date | Standard dates apply |
Expiration Date | April 6, 2021 |
Modified to Read (changes shown in bold italics):
Part 1. Overview
Key Dates:
Application Due Date(s) |
Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard dates apply |
Advisory Council Review | Standard dates apply |
Earliest Start Date | Standard dates apply |
Expiration Date | September 6, 2021 |
All other aspects of this FOA remain the same.
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]